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Background: Pancreatic ductal adenocarcinoma is associated with dismal prognosis. The detection of small
pancreatic tumors which are still resectable is still a challenging problem.
The aim of this study was to investigate the effect of decreasing the tube voltage from 120 to 80 kV on the
detection of pancreatic tumors.
Methods: Three scanning protocols was used; one using the standard tube voltage (120 kV) and current (160 mA)
and two using 80 kV but with different tube currents (500 and 675 mA) to achieve equivalent dose (15 mGy) and
noise (15 HU) as that of the standard protocol.
Tumors were simulated into collected CT phantom images. The attenuation in normal parenchyma at 120 kV was
set at 130 HU, as measured previously in clinical examinations, and the tumor attenuation was assumed to differ 20
HU and was set at 110HU. By scanning and measuring of iodine solution with different concentrations the
corresponding tumor and parenchyma attenuation at 80 kV was found to be 185 and 219 HU, respectively.
To objectively evaluate the differences between the three protocols, a multi-reader multi-case receiver operating
characteristic study was conducted, using three readers and 100 cases, each containing 0–3 lesions.
Results: The highest reader averaged figure-of-merit (FOM) was achieved for 80 kV and 675 mA (FOM= 0,850), and
the lowest for 120 kV (FOM= 0,709). There was a significant difference between the three protocols (p< 0,0001),
when making an analysis of variance (ANOVA). Post-hoc analysis (students t-test) shows that there was a significant
difference between 120 and 80 kV, but not between the two levels of tube currents at 80 kV.
Conclusion: We conclude that when decreasing the tube voltage there is a significant improvement in tumor
conspicuity.
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Pancreatic ductal adenocarcinoma (PDAC) is associated
with a dismal prognosis. The overall 5 year survival rate
is less than 5% and even after potentially curative sur-
gery this increases to only 20% [1]. Tumor size is an im-
portant prognostic factor and increasing size correlates
with a higher rate of unresectable tumors and decreased* Correspondence: jon.holm@gmail.com
†Equal contributors
1Division of Medical Physics, Karolinska University Hospital, Huddinge,
Stockholm 14186, Sweden
2Department of Clinical Science, Intervention and Technology (CLINTEC),
Karolinska Institutet, 17177 Stockholm, Sweden
Full list of author information is available at the end of the article
© 2012 Holm et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orsurvival [2]. For this reason it is important to detect pan-
creatic tumors while they are small and still resectable.
Technological advances in multi-detector computed
tomography (MDCT) combined with its wide availability
have made it the modality of choice for diagnosing and
staging pancreatic malignancies [3]. MDCT is highly
sensitive in detecting large tumors: 100% sensitivity for
tumors> 2 cm [4,5] but for small tumors, <2 cm, sensi-
tivity is lower (60-77%) [4,5]. Recent studies have shown
that MDCT and Magnetic Resonance Imaging (MRI)
have comparable diagnostic accuracy [6,7] with MRI
probably offering an advantage for liver metastases [7].
Our clinical impression, using a 64-channel MDCT andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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1–2 cm tumors is higher than is stated in the literature
but for very small tumors, <1 cm, the detection rate is
very low and needs to be improved.
Imaging pancreatic cancer with MDCT needs con-
trast enhancement in at least two phases, the pancre-
atic parenchymal phase (PPP) and the portal venous
phase (PVP). In the obligate PPP the normal pancre-
atic parenchyma enhances avidly whereas the vast ma-
jority of pancreatic adenocarcinomas (PDAC) are
hypointense, due to the high fibrous tissue content of
the tumor [8]. The key to the PDAC diagnosis is to
achieve as high an attenuation difference as possible
between the normal pancreatic parenchyma and the
tumor [9]. Reducing the tube voltage can increase this
contrast between tumor and normal parenchyma [10].
The main disadvantage of low tube voltage CT is the
increased image noise, which until recently has been
difficult to overcome because of limitations in the out-
put of the x-ray tubes. The increased contrast is
achieved by an increased photoelectric effect and a
decreased Compton scattering, resulting in a higher at-
tenuation of iodinated contrast media [10]. This
principle has been used to reduce the radiation dose
for CT of the thorax [11,12] and heart [13,14], in
patients with low body mass index (BMI) and in chil-
dren. In recent years, the technique has also been used
to improve CT angiography of the pulmonary arteries
[15-17] and to facilitate detection of hypervascular
liver lesions [18]. In a recent dual-energy MDCT
study, the low tube voltage technique improved the
enhancement of the pancreas and peripancreatic vascu-
lature in order to improve tumor conspicuity [19].
In this phantom study, the purpose was to investigate
whether a decrease of the tube voltage from 120 kVp to
80 kVp could improve the detection of small, low at-
tenuating, solid pancreatic tumors. We decided to assess
this in an experimental model whereby small hypoatte-
nuating simulated tumor lesions were mathematically
created in a phantom.Methods
Image acquisition
A phantom (CatphanW 600, The Phantom Laboratory,









A. 120 kVp 120 160 15 15
B. 80 kVp 80 500 15 17
C. 80 kVp 80 675 20 15scanner (LightSpeed VCT, GE Healthcare, Milwaukee,
USA), using three protocols A, B and C (Table 1). The
phantom consisted of five separate modules with differ-
ent properties. The CTP486 image uniformity module of
the Catphan phantom was scanned to acquire uniform
images. A body annulus, CTP579, was mounted onto
the phantom to better simulate the size of the human
trunk (Figure 1).
Protocol A utilizes a tube voltage of 120 kVp, which
is the tube voltage in clinical use for pancreatic
MDCT in our department. In the low voltage proto-
cols B and C, the tube voltage was decreased to 80
kVp. The tube current in protocol B was increased
from 160 mA to 500 mA to achieve the same mean
radiation dose as in protocol A (15 mGy volume com-
puted tomography dose index (CTDIvol)). In protocol
C, the tube current was increased to 675 mA, result-
ing in a higher radiation dose of 20 mGy CTDIvol, to
attain image noise comparable to that in protocol A
(15 HU).
For all three protocols, the X-ray tube rotation time
(0.6 seconds), detector configuration (64 x 0.625) and
helical pitch factor (0.516) were kept constant. The
acquired images were reconstructed using the soft re-
construction algorithm, a display field-of-view (DFOV)
of 25 cm, a slice thickness of 3 mm and with an interval
of 1.5 mm.Creation of cases and lesions
One hundred cases were created and used for each
protocol. Twenty-one images were acquired for each
case with the method described above. In 57 of the 100
cases we inserted 1 to 3 simulated lesions in random
positions.Figure 1 Image of the phantom. Image of the Catphan 600
phantom with the body anulus (CTP579) mounted on top of the
image uniformity module (CTP486).
Figure 2 (A-C) Image of the phantom scanned with protocol A, B and C. The image includes an inserted lesion with 10 mm diameter and a
contrast resulting from 120 kVp scanning (A), 80 kVp and 500 mA (B) and 80 kVp and 675 mA (C). The lesion has a random position inside the
inner circle.
Figure 3 The mean attenuation. The mean attenuation
(Hounsfield units) for the six test tubes containing different iodine
concentrations, positioned in the center position of an RMI phantom
and scanned at 120 kV and 80 kV.
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They were calculated by pixel-wise integration of a
hemisphere, which is mathematically expressed by:
RR
f x; yð Þdxdy ¼
RR ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
r2  x2  y2dxdy
p
ð1Þ
where r is the radius of the lesion and x and y are the
Cartesian coordinates in the axial plane of the CT scan-
ner. The integration limits in the xy plane were derived
from DFOV information and the size of the image
matrix (512 x 512), and are in increments of 0.5 mm in
both x and y directions. The integration in z direction
is given from the slice thickness and its different posi-
tions. Due to the symmetry, integrations were only car-
ried out in one of the quadrants of the hemisphere. The
integrations were performed numerically using Mathe-
matica software (Wolfram Research, Champaign, USA).
Lesions with a diameter of 2, 3, 4, 5, 6, 8 and 10 mm
were created (Figure 2). Because of the 3 mm slice
thickness, many of the pixels in the smaller lesions did
not only represent the attenuation of the lesion itself,
but also the attenuation of the background phantom
material, causing partial volume effect problems. Since
the lesions had an attenuation close to that of the sur-
rounding phantom material, the CT number for these
pixels was computed by assuming a linear combination
of the μ values according to their volumetric propor-
tions [20].
Determination of parenchymal and lesion attenuation
After determining the proportion of lesion and sur-
rounding phantom material in the voxels as described in
the previous section, the actual attenuation of the lesion
and parenchyma was measured and calculated for both
tube voltages. Previous measurements from 15 clinical
CT examinations of the pancreas with our standard
protocol (120 kVp and 0.75 g I/kg body weight) yielded
an attenuation of the normal pancreatic parenchyma of
approximately 130 HU in the PPP. These measurementshad been performed in examinations reconstructed in
0.625 mm slices, to avoid the effect of partial volume
averaging, and by using circular regions of interest
(ROIs). The lesions that are usually missed have an at-
tenuation very similar to that of the normal pancreas.
Therefore we assumed that the simulated lesions’ at-
tenuation differs from the background by only 20 HU at
120 kVp.
Iodine contrast medium (Iomeron 400 mg I/ml) was
diluted with water in six different concentrations (1.1,
2.2, 3.2, 4.3, 5.4 and 6.5 mg I/ml) in standard 10 ml
plastic vials. These were inserted into the center pos-
ition of a homogenous phantom (RMI Model 461A,
Gammex/RMI, Middleton, USA), which was scanned at
120 kVp and 80 kVp. The attenuation values were plot-
ted against the iodine concentration and correlated
linearly (Figure 3). By using this information about at-
tenuation at both tube voltages, all pixel values were
calculated based on the assumptions detailed in the pre-
vious section.
Figure 5 The image noise. The image noise at 80 kV and 120 kV is
shown for different tube currents. From the regression equations
one can see that the tube current must be increased from 160 mA
to 675 mA when changing the tube voltage from 120 kV to 80 kV to
attain the same image noise of 15 HU.
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The simulated lesions were inserted into the CT images
by subtracting the lesion pixel matrix from the uniform
phantom image matrix. The phantom background was
also adjusted by matrix addition to achieve the same at-
tenuation as the parenchyma. All matrix operations were
carried out using Matlab (The Mathworks, Natick,
USA). The lesions were randomly positioned in both xy
and z planes using the random number generator in
Matlab.
Radiation dose and image noise
The CTDI100 were measured by using a pencil ionization
chamber (DCT10, Wellhöfer, Germany). The measure-
ments were performed with the chamber inside the cen-
tral (CTDI100,c) and the four peripheral holes (CTDI100,p)
of a 32 cm standard polymethylmethacrylate (PMMA)
body phantom. Scans were made for both tube voltages
at four different tube currents (Figure 4). Calculations
for CTDIvol were performed by using the two well-
known equations [21]:




CTDIvol ¼ CTDIwpitch ð3Þ
Image noise was measured in the phantom’s image uni-
formity module. The phantom was scanned with both
tube voltages at different tube currents (Figure 5). For
each scan, a circular region of interest (ROI) was used
with its size adjusted to cover the whole inner part of the
phantom. The standard deviation of the pixels inside each
ROI was registered as the amount of the image noise.Figure 4 The radiation dose. The radiation dose measured as the
CTDIvol at 80 kV and 120 kV is shown for different tube currents.
From the regression equations one can see that the tube current
must be increased from 160 mA to 500 mA when changing the tube
voltage from 120 kV to 80 kV to attain the same CTDIvol of 15 mGy.Both the radiation dose and the image noise were plot-
ted against the tube current and correlated using appro-
priate functions (Figures 4 and 5). Regression equations
were used to calculate the tube currents for protocols B
and C.Viewer performance
A standard Picture Archiving and Communicating Sys-
tem (PACS) workstation (Sectra, Linköping, Sweden)
was used, with either a one mega pixel color monitor
(RadiForce R12, EIZO Nanao Corporation, Ishikawa,
Japan) or a three mega pixel grey scale monitor (Radi-
Force G31, EIZO Nanao Corporation, Ishikawa, Japan).
The monitors were calibrated according to DICOM part
14 using a dedicated quality control tool (RadiCS, EIZO
Nanao Corporation, Ishikawa, Japan). The images were
scaled to fit the monitor, and the radiologists were not
allowed to use the zoom tool. The window center was
set at the attenuation of the pancreatic parenchyma,
which was 130 HU for the 120 kVp images and 217
HU for the 80 kVp examinations. The window width
was set to 400 HU for all protocols. Viewing time was
unrestricted.
Three radiologists with 24, 21 and 7 years of experi-
ence in CT imaging participated in the study. For each
scanning protocol, the radiologists were instructed to in-
dependently read the 100 cases. They were blinded to
CT scanning parameters and to lesion characteristics.
They were instructed to indicate suspicious lesions with
an arrow marker and rate their level of confidence in the
detection of each lesion according to an arbitrary scale
ranging from 1 to 4, where 4 indicates the highest confi-
dence and 1 the lowest (Table 2).
Table 2 Confidence levels used for rating suspected
lesions. The highest rating per case was used as the
ROC rating
Rating Confidence level
0 Definitely no lesion (no marking)
1 Probably not a lesion
2 Possibly a lesion
3 Probably a lesion
4 Definitely a lesion
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randomly to minimize the memory effect. To familiarize
the radiologists to the task, a training session was con-
ducted where they were presented with 10 cases in
which the lesions were marked with an arrow. Examples
of typical artifacts present in the images were also
indicated.
The readers were asked to mark and grade the lesions
in two different reading sessions. In the first viewing ses-
sion they were not allowed to adjust the window setting.
In the second viewing session all readers were asked to
reinterpret all images, the order of which had been rear-
ranged to minimize the memory effect, but now the
readers were instructed that they were free to adjust the
window setting according to their own preferences.
Statistical analysis
The study was analyzed using the receiver operating
characteristic method (ROC). The highest rated mark
per case was used for the ROC evaluation and the rest
of the information was used for descriptive statistics.
The collected ROC data were statistically analyzed using
DBM-MRMC software version 2.2 [22]. The software
first calculated a figure-of-merit (FOM) for each reader
and protocol. This was performed by summing the num-
ber of ratings for each level of confidence for every actu-
ally negative and actually positive case. The false positive
fraction (FPF) and the true positive fraction (TPF) were
calculated for all possible cut points. A cut point wasFigure 6 (A-B) ROC curves with fixed and free-choice window setting
window setting (A) and free-choice setting (B). The FPF is plotted against tdefined as the point where, as above, the readers’ inter-
pretation is considered as a true positive for an actual
positive (tumor case) or a false positive for an actual
negative (non-tumor case) [23]. The TPF was then plot-
ted against the FPF and the points were correlated (tra-
pezoidally) and extrapolated to the point of (1,1). The
area under the curve (AUC) was the FOM and could be
interpreted as the probability that a randomly chosen,
actually positive case was rated higher than a randomly
chosen, actually negative case [24].
The software performed an analysis of variance
(ANOVA) on the FOMs to test any difference between
the various scanning protocols, as well as a following
post-hoc analysis (t-test) to determine exactly where the
differences were. Because we had 100 cases but only 3
readers, the analysis was performed by treating the cases
as random samples and the readers as fixed samples.
Because the ROC methodology cannot handle infor-
mation about the number of lesions per case and their
localization, the lesion localization fraction (LLF) was
calculated. A lesion localization (LL) was defined as a
mark that was located not more than 1 cm from a le-
sion, and the LLF is the LL divided by the total number
of lesions. The corresponding non-lesion localization
fraction (NLF) was also calculated. A non-lesion
localization (NL) was defined as a mark that was
located more than 1 cm from a lesion, and the NLF is
the NL divided by the total number of cases.Results
Determination of parenchymal and lesion attenuation
The attenuation values for the lesions and the paren-
chyma at 120 kVp had previously been determined in
clinical examinations as 110 HU and 130 HU respect-
ively, and were therefore used for the simulated lesions
and parenchyma at 120 kVp. The corresponding at-
tenuation values for the simulated lesions and the
simulated normal parenchyma scanned at 80 kVp were
183 HU and 217 HU respectively. Thus, the attenuation. ROC curves for each scanning protocol interpreted with the fixed
he TPF for all possible cut points and correlated trapezoidally.
Table 4 Inter-protocol comparisons with the highest
differences between the FOMs and the lowest p-values at
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as compared to 120 kVp.the top
Protocol comparison Δ FOM P-value
C* - A* 0.1419 <0.0001
C* - A 0.1372 <0.0001
C - A* 0.1283 <0.0001
C - A 0.1237 <0.0001
B* - A* 0.0979 0.0003
B - A* 0.0943 0.0005Radiation dose and image noise
When the tube voltage was decreased from 120 kVp to
80 kVp, the tube current had to be increased to 500 mA
to achieve an equivalent absorbed radiation dose and
adjusted up to 675 mA to achieve similar image noise.
The CTDIvol for protocols A and B were 15 mGy and
for protocol C 20 mGy.B* - A 0.0933 0.0006
B - A 0.0897 0.0010
C* - B 0.0475 0.0797
C* - B* 0.0439 0.1053
C - B 0.0340 0.2097
C - B* 0.0304 0.2621
C* - C 0.0135 0.6174
A - A* 0.0046 0.8644
B* - B 0.0036 0.8941Viewer performance
The FOMs for each reader and scanning protocol, deter-
mined from the areas under the ROC curves (Figure 6),
are presented in Table 3. The highest reader-averaged
FOM was acquired for protocol C using a free-choice
window setting. The lowest reader-averaged FOM was
acquired for protocol A, using a free-choice window
setting. The reader-averaged FOM for each protocol,
with range in paranthesis as a measure of the interob-
server variablility, were as follows: A: 0.713 (0.679-
0.741), B: 0.803 (0.785-0.829), C: 0.837 (0.834-0.840),
A*: 0.709 (0.706-0.716), B*: 0.807 (0.771-0.842) and
C*:0.850 (0.833-0.876). The reader-averaged FOMs dif-
fered significantly (p< 0.0001), which in this analysis
means that at least two, but not necessarily all, proto-
cols differ. Post-hoc analysis showed better lesion detec-
tion when the tube voltage was decreased from 120 to
80 kVp but not when the tube current was increased
from 500 to 675 mA at 80 kVp (Table 4). Similar results
were achieved by using the predefined fixed window
setting and a free-choice window setting. The TPF and
FPF for all possible cut points and protocols are pre-
sented in table 5.
When the LLF and NLF were analyzed for each lesion
size (Figures 7 and 8), smaller lesions were detected with
80 kVp than with 120 kVp. A major portion of the
5 mm lesions were detected at 80 kVp while only a small
fraction of these were detected at 120 kVp. Also, a major
proportion of the 4 mm lesions were detected at 80 kVp




A. 120 kVp B. 80 kVp C. 80 kVp
1 0.720 0.785 0.840
2 0.741 0.795 0.836
3 0.679 0.829 0.834
Average 0.713 0.803 0.837measuring between 2 and 3 mm was poor in all
protocols.Discussion
The Catphan phantom was utilized in this study to
represent the normal pancreatic parenchyma and was
scanned by using various acquisition protocols, essen-
tially varying the tube voltage between 120 kVp and
80 kVp. Computer-simulated, low attenuating lesions
of various diameters, representing hypovascularised
solid pancreatic tumors, were inserted into the ensuing
phantom images. The rationale for using a low kilovol-
tage protocol was to achieve a higher attenuation dif-
ference between the tumor and the pancreatic
parenchyma, in order to improve tumor conspicuity
and delineation. Generally, lesions with attenuation
nearly identical to that of the normal pancreatic par-
enchyma are difficult to visualize. By inserting 110 HU
computer-simulated lesions, 20 HU less than that ofr with a reader-averaged FOM. * Indicates a
Protocol
Free-choice window setting





Table 5 TPF (sensitivity) and The FPF (1 – specificity) for all possible cut points and protocols
A. 120 kVp B. 80 kVp C. 80 kVp
Cut point TPF (1-FNF) FPF (1-TNF) TPF (1-FNF) FPF (1-TNF) TPF (1-FNF) FPF (1-TNF)
0-1 0.678 0.372 0.731 0.357 0.766 0.287
1-2 0.608 0.271 0.708 0.209 0.743 0.163
2-3 0.421 0.109 0.614 0.031 0.655 0.016
3-4 0.211 0.000 0.462 0.000 0.532 0.000
A*. 120 kVp B*. 80 kVp C*. 80 kVp
Cut point TPF (1-FNF) FPF (1-TNF) TPF (1-FNF) FPF (1-TNF) TPF (1-FNF) FPF (1-TNF)
0-1 0.608 0.326 0.655 0.132 0.749 0.178
1-2 0.561 0.194 0.655 0.078 0.737 0.109
2-3 0.433 0.085 0.596 0.000 0.673 0.000
3-4 0.298 0.000 0.509 0.000 0.591 0.000
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clinical situation. When the tube voltage was
decreased from 120 to 80 kVp, the mean photon en-
ergy decreased in parallel from 56.8 to 43.7 keV [18].
This lower value was closer to the K edge of iodine
(33.2 keV) resulting in higher X-ray absorption and a
significantly higher attenuation (67%) of the back-
ground (i.e. normal pancreatic tissue). Consequently,
the attenuation difference between the digital lesions
and the pancreatic background increases by 70% (from
20 HU to 34 HU).
The post-hoc analysis revealed significantly better le-
sion detection at 80 kVp than at 120 kVp, which means
that smaller lesions and more of them are detected at
80 kVp. The main consideration for applying a lower
tube voltage was the increase of image noise. In proto-
col C, we established the same image noise as in proto-
col A by using the maximum tube current possible
with our 64-channel MDCT (675 mA). However, for
lesions measuring ≥5 mm, the LLF at 80 kVp was not
improved when the tube current was increased to
675 mA in order to establish the same image noise as
in the 120 kVp protocol. In contrast, an increase of theFigure 7 (A-B) The reader-averaged LLF. Interpreted with the fixed (A) a
(2 – 10 mm) and scanning protocol.tube current in the 80 kVp protocol (C) to achieve
similar noise as in the 120 kVp protocol (A) improved
the LLF for lesions with a diameter ≤4 mm.
The receiver operating characteristic (ROC) method
has long been one of the standard methods in radiology
to analyze and compare diagnostic accuracy [25].
The ROC method is very powerful because it estimates
and reports all combinations of sensitivity and specificity
that a diagnostic test is able to provide [26] and it is
therefore used in this study. In the ROC paradigm, the
observer is given a number of cases in some of which
some kind of abnormality is present. The observer is
asked to rate every case depending on how confident he
or she is about whether there is an abnormality some-
where in that case.
The resulting 2 x 2 truth-response table defines cor-
rect decisions (true positives (TP) and true negatives
(TN)) and incorrect decisions (false positives (FP) and
false negatives (FN)) in comparison to a gold standard.
Pancreatic cancer incidence peaks between 60 and
80 years of age [27]. The risk of developing a radiation-
induced cancer is markedly age-dependent. Given an
estimated less than 5% 5-year survival rate, the risk tond free-choice (B) widow setting. Presented for each lesion size
Figure 8 The reader-averaged NLF for each scanning protocol
interpreted with both free-choice and fixed window settings.
The smallest fractions (< 20%) of missed lesions was attained for the
80 kV protocol interpreted with the free-choice window setting.
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in order to achieve a technically optimal MDCT is negli-
gible. We therefore believe that for patients with a high
probability of pancreatic malignancy, the examination
protocol should be tailored to achieve optimal tumor
conspicuity. The radiation dose must, however, be taken
into account for patients with hereditary or predisposing
factors for pancreatic tumors (for example familiar syn-
dromes and chronic pancreatitis) and subjects with the
multiple endocrine neoplasia syndrome Type I (MEN-I)
who undergo repeated screening controls.
When designing these examination protocols, it is
therefore important to remember that the radiation dose
will increase when the tube voltage is decreased because
at the same time the tube current needs to be adjusted
to maintain similar image noise. The reason for this is
that the image noise is a function of the dose to the de-
tector and not to the patient.
This study has some limitations. In daily clinical prac-
tice we do not consider the low kilovoltage protocols
suitable for large patients (> 85 kg) because of the high
image noise, despite the increase in radiation dose. Real
tumors are not uniformly spherical in shape and are not
always located in a perfectly homogenous background.
Even though the vast majority of PDACs are hypoatte-
nuated to pancreatic parenchyma, it should be noted
that 11% of solid pancreatic malignancies are isoattenu-
ating on CT [9]. In these cases the presence of second-
ary signs such as pancreatic and/or biliary duct
dilatation can indicate the existence of a tumor. Also,
the attenuation used as reference for pancreatic paren-
chyma (130HU) and the pancreatic cancers (110HU)
were measured in a limited number of patients (n = 15).
In the experimental situation a 20 HU attenuation differ-
ence between pancreas and tumor was thus assumedwheras in the clinical situation there is a variation in
this respect. Furthermore, the simulated tumors were
inserted into already reconstructed images, meaning
that the lesions were not affected by the modular trans-
fer function (MTF) of the system. In future studies, the
lesions may instead be convolved with the point-spread
function (PSF) before inserting them into the images in
order to avoid this inconsistency.
Moreover, the study was designed as a free-response
ROC (FROC), but the evaluation was performed as an
ROC. Because two of the readers did not generate an ap-
preciable amount of NLs for protocols B* and C*, the
statistical analysis became less reliable. An ROC analysis
was therefore performed, complemented with descriptive
statistics, so that the information about the location and
the number of lesions was not lost.
One of the readers did not use the same type of moni-
tor (three mega pixel grey scale) as the other two. A one
mega pixel color monitor was used instead. However, all
monitors were calibrated according to DICOM part 14,
and since CT images do not require high-resolution
monitors, this difference was considered to be of small
importance.
Conclusion
In conclusion, by using this experimental model, we
have shown that the low-kilovoltage, high-current
MDCT improved the depiction of small, minimally
hypodense, solid pancreatic lesions. However, further
studies are needed to assess what the technique yields in
the clinical setting.
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